Friday, 28 February 2014

The first autonomous drones that flock like birds are Hungarian!

Our cofounder and Academic Director, Tamás Vicsek, has made it to Nature Magazine again with an absolutely fascinating project: the creation of autonomous drones that flock like birds.

Tamás Vicsek
He coordinates the COLLMOT Robotic Research Project, a five-year program on the complex structure and dynamics of collective motion, funded by EU ERC.

Based on their findings on the collective behavior of birds such as pigeons, his team of Hungarian researchers created 10 self-organizing drones that follow rules of collective motion. "We came to the conclusion that one of the best ways to understand how animals move together is to build robots - flying robots", said Vicsek.

Equipped with GPS trackers and radios that allow them to navigate in formation, the quadcopters were tested in open-field environment for maximum authenticity. Instead of a central control, the drones use a flocking algorithm when their flying path becomes jammed, and wait for their turn while hovering in place.

Watch the video to see them in action:

Friday, 21 February 2014

FirmNet Online rebranded to OrgMapper

Our online organizational diagnostic tool, FirmNet Online, has undergone a rebranding, and will now officially become OrgMapper.

The new name focuses on the essence of the solution at hand, and crystallizes in a single word the underlying methodology our product offers.

Visit to see the rebranding for yourself.

Thursday, 20 February 2014

Primus Capital invests in the expansion of Maven7

Official press release on the recent happenings in our company's life:

Budapest, Hungary – Boston, MA
Primus Capital Fund Management Ltd. is investing more than 170 million forints (approx. 750,000 US dollars) acquiring a minority stake in Maven Seven Network Research Ltd. (Maven7), a provider of unique network research-based analyses and services. Through the capital investment, the 4-year-old company will further develop its online diagnostic tool, OrgMapper, and take it to Western European and overseas markets. It will also strengthen the sales activities of its US subsidiary and further develop its network analysis services for the media and pharmaceutical sectors.

Maven7 applies the latest results and innovations in network science to the business environment. Among its co-founders are such internationally acclaimed scientists of the discipline as Albert-László Barabási (Northeastern and Harvard Universities) and Tamás Vicsek (Hungarian Academy of Sciences, ELTE), who rightfully ensure the company's academic credibility.

Maven7 supports business decisions by transforming large amounts of hard-to-interpret data into actionable business intelligence.

The company's online Software as a Service (SaaS) platform, OrgMapper, allows its users, primarily in the business consulting sector, to conduct analyses in organizational development, the media, and the pharmaceutical industry, on the basis of which consultancies can provide M&A advisory, change management and other services to their customers.

Maven7 is the 10th investment of Primus Capital. "International competitiveness and execution built on the expertise of Central European physicists and engineers – this is the strategy of Maven7 and Primus Capital. We are proud to be working with such a fast-growing company and a team of extremely talented professionals in order to achieve international growth", added Zoltán Bruckner, investment director at Primus Capital.